Novel Innate Immune Genes and Asthma

新型先天免疫基因与哮喘

基本信息

  • 批准号:
    7977187
  • 负责人:
  • 金额:
    $ 30.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-03-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

We recently discovered the CATERPILLER family which share structural similarities with the NB-LRR (nucleotide-binding, leucine-rich repeat) super-family of disease resistance (R) proteins that constitutes the plant immune system. In the animal kingdom, this family is also known as NOD or NLR. The clinical importance of this family is underscored by the genetic linkage of family members to a number of immunologic disorders. Among the human gene family members, several of these appear to mediate negative regulatory function in controlling an overzealous inflammatory response. Most notable is the Monarch-1 protein which blocks the function of NF-kB inducing kinase (NIK). Inhibition of NIK reduces the expression of an array of chemokines with relevance in asthma. Gene profiling of induced sputum from mildly asthmatic individuals suggests that the Monarch-1 gene is reduced in these individuals relative to controls, supporting the inhibitory role of this gene during inflammation. Another group of family members regulates IL-1 production. Most notable among these is cryopyrin which mediates formation of the inflammasome complex upon stimulation with a number of inducers. The inflammasome complex is required for procaspase 1 processing to mature caspase 1. In turn, caspase-1 is required for the processing of pro-IL-1 and pro-IL-18 to their mature forms. IL-1 and IL-18 are respectively important in inflammation and TH2 skewing. Cryopyrin is also important in mediating macrophage necrosis which exacerbates inflammation. Thus there are compelling reasons to believe that Monarch-1 and cryopyrin have crucial roles in asthma, however there is no in vivo data to indicate that this is the case. Furthermore we have shown that both of these proteins are ATP-binding proteins, and they exhibit ATPase activity, thus providing ways to modulate their function, which might be important leads to drug discovery. The goals of this proposal are: (1) To study the relevance of Monarch-1 in three animal models of asthma (OVA-induced, endotoxin, and house dust mite and delineate the biochemical effects of Monarch-1 in vivo and ex vivo. (2) To study the relevance of cryopyrin and a cryopyrin-adaptor (ASC) in asthma. (3) To study and identify factors which modulate the nucleotide-binding properties and ATPase function of Monarch-1 and cryopyrin.
我们最近发现了与NB-LRR共享结构相似性的Caterpiller家族 (核苷酸结合,富含亮牙 植物免疫系统。在动物界,这个家庭也被称为点头或NLR。临床 这个家庭的重要性被家庭成员的遗传联系强调了 免疫疾病。在人类基因家族成员中,其中一些似乎是在调解 负责控制过度狂热反应的负调节功能。最值得注意的是 君主-1蛋白阻断NF-KB诱导激酶(NIK)的功能。抑制NIK减少 与哮喘相关的一系列趋化因子的表达。诱导痰的基因分析 从轻度哮喘的个体中表明,这些个体中的君主-1基因减少了 相对于对照,支持该基因在炎症过程中的抑制作用。另一组家庭 成员调节IL-1的生产。其中最值得注意的是冷冻蛋白,它介导 许多诱导剂刺激后的炎性体复合物。炎性体综合体是 procaspase 1处理至成熟caspase 1的要求。反过来,caspase-1需要 将Pro-IL-1和Pro-IL-18处理成熟形式。 IL-1和IL-18在 炎症和Th2偏斜。冷冻蛋白在介导巨噬细胞坏死中也很重要。 加剧炎症。因此,有令人信服的理由相信Monarch-1和冷冻蛋白 在哮喘中具有关键作用,但是没有体内数据可以表明情况。 此外,我们已经表明,这两种蛋白质都是ATP结合蛋白,它们表现出来 ATPase活性,因此提供了调节其功能的方法,这可能是重要的导致药物 发现。该提案的目标是:(1)研究三只动物中君主-1的相关性 哮喘的模型(OVA诱导的,内毒素和房屋粉尘螨,并描绘出生化效应 Monarch-1体内和Ex Vivo。 (2)研究冷冻蛋白和冷冻蛋白适应器(ASC)的相关性 哮喘。 (3)研究和确定调节核苷酸结合特性和ATPase的因素 Monarch-1和冷冻蛋白的功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jenny P Ting其他文献

Jenny P Ting的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jenny P Ting', 18)}}的其他基金

Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
细胞内先天免疫受体在癌症抑制和免疫治疗中的作用
  • 批准号:
    10654660
  • 财政年份:
    2019
  • 资助金额:
    $ 30.99万
  • 项目类别:
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
细胞内先天免疫受体在癌症抑制和免疫治疗中的作用
  • 批准号:
    10451800
  • 财政年份:
    2019
  • 资助金额:
    $ 30.99万
  • 项目类别:
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
细胞内先天免疫受体在癌症抑制和免疫治疗中的作用
  • 批准号:
    10217045
  • 财政年份:
    2019
  • 资助金额:
    $ 30.99万
  • 项目类别:
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
细胞内先天免疫受体在癌症抑制和免疫治疗中的作用
  • 批准号:
    10019472
  • 财政年份:
    2019
  • 资助金额:
    $ 30.99万
  • 项目类别:
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
用于输送疫苗和佐剂的新型纳米颗粒平台
  • 批准号:
    9229872
  • 财政年份:
    2014
  • 资助金额:
    $ 30.99万
  • 项目类别:
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
用于输送疫苗和佐剂的新型纳米颗粒平台
  • 批准号:
    8642227
  • 财政年份:
    2014
  • 资助金额:
    $ 30.99万
  • 项目类别:
Engineering Monodisperse Particulate Vaccines to Tailor Immunological Responses
设计单分散颗粒疫苗以定制免疫反应
  • 批准号:
    9337971
  • 财政年份:
    2014
  • 资助金额:
    $ 30.99万
  • 项目类别:
Discovery of New Innate Immune Pathways in Viral Recognition
病毒识别中新先天免疫途径的发现
  • 批准号:
    8653231
  • 财政年份:
    2014
  • 资助金额:
    $ 30.99万
  • 项目类别:
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
用于输送疫苗和佐剂的新型纳米颗粒平台
  • 批准号:
    9307701
  • 财政年份:
    2014
  • 资助金额:
    $ 30.99万
  • 项目类别:
Novel Nucleic Acid Sensing NLRs and Innate Immunity to Viruses
新型核酸传感 NLR 和病毒先天免疫
  • 批准号:
    9233910
  • 财政年份:
    2014
  • 资助金额:
    $ 30.99万
  • 项目类别:

相似海外基金

The effects of alcohol metabolism on hepatic and cardiac energy state and function
酒精代谢对肝脏和心脏能量状态和功能的影响
  • 批准号:
    10506788
  • 财政年份:
    2022
  • 资助金额:
    $ 30.99万
  • 项目类别:
The effects of alcohol metabolism on hepatic and cardiac energy state and function
酒精代谢对肝脏和心脏能量状态和功能的影响
  • 批准号:
    10679083
  • 财政年份:
    2022
  • 资助金额:
    $ 30.99万
  • 项目类别:
INTERCALATED CELLS OF THE DISTAL NEPHRON DEFEND THE URINARY SYSTEM
远端肾单位的嵌入细胞保护泌尿系统
  • 批准号:
    9072614
  • 财政年份:
    2015
  • 资助金额:
    $ 30.99万
  • 项目类别:
Intercalated Cells of the Distal Nephron Defend the Urinary System
远端肾单位的闰细胞保护泌尿系统
  • 批准号:
    8532896
  • 财政年份:
    2012
  • 资助金额:
    $ 30.99万
  • 项目类别:
Intercalated Cells of the Distal Nephron Defend the Urinary System
远端肾单位的闰细胞保护泌尿系统
  • 批准号:
    8279970
  • 财政年份:
    2012
  • 资助金额:
    $ 30.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了